Abbey Evans
Impact in
- Virology top 10%
- HIV Research and Treatment
- Biotechnology top 10%
- Transgenic Plants and Applications
Papers in
- Virology 6
- HIV Research and Treatment 6
-
- HIV/AIDS Research and Interventions 3
- HIV/AIDS drug development and treatment 2
- Co-authors
- Robin J. Shattock (8 shared papers)Paul Christou (3 shared papers)Evangelia Vamvaka (3 shared papers)Teresa Capell (3 shared papers)Koreen Ramessar (2 shared papers)Hannah M. Cheeseman (3 shared papers)Barry R. O’Keefe (2 shared papers)Paul Ziprin (2 shared papers)
- Journals
- Journal of Virology (1 paper)Plant Biotechnology Journal (1 paper)Plant Cell Reports (1 paper)Proceedings of the National Academy of Sciences (1 paper)Journal of Pharmaceutical Sciences (1 paper)
- Partner nations
- United KingdomUnited StatesSpain
In The Last Decade
Abbey Evans
9 papers receiving 177 citations
Peers
Comparison fields: 5 of 46
- Virology 42
- Biotechnology 63
- Immunology 43
- Microbiology 12
- Infectious Diseases 31
Countries citing papers authored by Abbey Evans
This map shows the geographic impact of Abbey Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abbey Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abbey Evans more than expected).
Fields of papers citing papers by Abbey Evans
This network shows the impact of papers produced by Abbey Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abbey Evans. The network helps show where Abbey Evans may publish in the future.
Co-authors
The 25 scholars most cited alongside Abbey Evans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 39 | |
| 2 | 2018 | 30 | |
| 3 | 2016 | 25 | |
| 4 | 2016 | 21 | |
| 5 | 2016 | 20 | |
| 6 | 2014 | 19 | |
| 7 | 2022 | 16 | |
| 8 | 2006 | 8 | |
| 9 | 2014 | 2 |
About Abbey Evans
Abbey Evans is a scholar working on Virology, Infectious Diseases, Biotechnology, Molecular Biology and Immunology, having authored 9 papers that have together received 180 indexed citations. Recurring topics across this work include HIV Research and Treatment (6 papers), HIV/AIDS Research and Interventions (3 papers), Transgenic Plants and Applications (3 papers), HIV/AIDS drug development and treatment (2 papers), Plant tissue culture and regeneration (2 papers), Immunotherapy and Immune Responses (1 paper), Monoclonal and Polyclonal Antibodies Research (1 paper) and Reproductive tract infections research (1 paper). The work is most often cited by research in Virology (42 citations), Biotechnology (63 citations), Immunology (43 citations), Microbiology (12 citations) and Infectious Diseases (31 citations). Abbey Evans has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include Robin J. Shattock, Paul Christou, Evangelia Vamvaka, Teresa Capell, Koreen Ramessar, Hannah M. Cheeseman, Barry R. O’Keefe, Paul Ziprin, Natalia Olejniczak and Deborah King. Their work appears in journals such as Journal of Virology, Plant Biotechnology Journal, Plant Cell Reports, Proceedings of the National Academy of Sciences and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.